The Aiforia® Lymph Node Metastasis AI model supports the detection and quantification of metastases of breast cancer, melanoma, and colorectal cancer in lymph nodes from whole slide images. Aiforia Technologies Plc, Press Release, September...

Upcoming Aiforia webinar Evaluation of HER2-low and ultralow status of advanced breast carcinomas Monday, September 29, 2025 3-4pm CEST | 9-10 am EDT REGISTER NOW Join this webinar to discover how digital pathology with AI evaluation...

Researchers in the University of Tennessee, Knoxville’s Tickle College of Engineering are using artificial intelligence and machine learning to provide treatment plans to breast cancer patients more quickly by analyzing pathology reports...

From the Cureus Journal of Medicine, researchers publish a pilot study of breast cancer Histopathological Image Classification Using Google Teachable Machine. Read the Abstract below. Abstract Introduction Breast cancer remains a major...

Nijmegen, the Netherlands, and Louvain-la-Neuve, Belgium — Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, and Telemis, a specialist in medical imaging and digital pathology, today announced a...

Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics Aiforia Technologies Plc, Press Release, June 24, 2025 at 9:00 a.m. EEST Aiforia Technologies Plc launches a new CE-IVD marked clinical AI solution...